Physician profile
Timothy T Chen
NPI 1720079056
$992.30
in general payments reported to CMS, 2019-2025
12 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.44 · 2020: $38.00 · 2021: $15.47 · 2022: $22.57 · 2023: $18.94 · 2024: $579 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $248.48 | 2024 | Linq II |
| Novartis Pharmaceuticals Corporation | $210.46 | 2024-2025 | |
| Boston Scientific Corporation | $146.47 | 2024 | Watchman Flx |
| Alnylam Pharmaceuticals INC. | $125.00 | 2025 | Amvuttra |
| Amgen INC. | $69.66 | 2025 | Repatha, Repatha |
| Abbott Laboratories | $56.98 | 2021-2023 | Mitraclip |
| Organogenesis INC. | $38.00 | 2020 | |
| Novo Nordisk INC | $24.62 | 2025 | Ozempic |
| Pfizer INC. | $21.76 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.88 | 2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $15.55 | 2024 | Camzyos |
| Allergan, INC. | $14.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.